Gynecologic Cancer News

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting.

Satish Gopal, MD, MPH, feels honored to receive this year’s ASCO Humanitarian Award.

Participation in cancer-related clinical trials could increase dramatically if researchers screened and recruited individuals using routine care patient-reported outcomes, according to results published in JAMA Oncology.

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.

Men vaccinated for HPV less frequently developed all related cancers, particularly head and neck cancers, according to findings scheduled for presentation at ASCO Annual Meeting.

In France, HPV vaccination at school significantly increased vaccination coverage among adolescents aged 11 to 14 years, according to study results published in JAMA Network Open.

Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.

A 5-year interval between cervical cancer screenings using HPV testing does not increase risk for cervical precancer detection compared with cytology every 3 years and may be a more effective screening method long term, researchers report.

The FDA approved expanded indications for two HPV tests allowing for the patient to self-collect a vaginal swab in a health care setting when it is not possible for the clinician to collect a cervical specimen, according to a press release.

Patients participating in clinical trials for anticancer drugs do not gain a survival benefit compared with individuals who received routine care, according to study results published in JAMA.